Delivery Order SPE2DB24D2205-SPE2DB24FDSUQ

Award Date 4/17/24
Potential Completion Date 5/8/24
Potential Value $9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product GAMUNEX-C 20 GRAM/200 ML VIAL 200ML to the Defense Logistics Agency (DLA). The $14,295.00 firm fixed-price delivery order has a completion date of June 10, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical valued at $7,147.50. The contract is for the provision of GAMUNEX-C 20 gram/200 ml vial pharmaceuticals, with a performance period through April 3, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical, in support of the Department of Defense (DoD) and other government agencies. The contract has an Indefinite Delivery Contract (IDC) vehicle valued up to $999,999,999.00 through December 31, 2025, serving as the primary means for Amerisourcebergen to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) is a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. Under this contract, Amerisourcebergen will deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceutical products and medical supplies to the Department of Defense (DoD) and other government agencies. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, has a ceiling value of $14,839.64, and runs through May 3, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen will provide a comprehensive range of medications, including specialty, brand name, generic, and over-the-counter drugs, as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of a wide range of pharmaceutical products and medical supplies to the U.S. Defense Logistics Agency (DLA) Troop Support Medical program. The contract is a single-award Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, serving as the primary vehicle for Amerisourcebergen to deliver medications, specialty drugs, and critical care materials to DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) with a delivery order valued at $1,443.79. The contract has a period of performance through March 12, 2024 and is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is for the delivery of pharmaceutical products and medical supplies to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order worth $8,459.74 from the Defense Logistics Agency (DLA) Troop Support Medical for the provision of pharmaceutical products and medical supplies. The award is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDSUQ
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of Gammagard S-D 10 G (IGA), a pharmaceutical product, to the Defense Logistics Agency (DLA). The firm-fixed-price contract has a ceiling value of $8,970.40 and an ultimate completion date of May 8, 2024.

Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.

Generated 7/17/24, 9:33 AM